insights_auto
Varför har 524494 gått ned 3,51%?
Gå på djupetchevron_right
524494:BOM
IPCA Laboratories Ltd
1Â 845,00Â INR
arrow_downward
−3,51%(−67,20) 1 d
16 okt., 15:30:00 GMT+5:30 · INR
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för 524494 …
Öppen
1Â 913,95Â INR
Högt
1Â 913,95Â INR
LÃ¥gt
1Â 812,60Â INR
Börsvärde
468,21Â md
Genomsn. vol.
27,90Â tn
Volym
12,00Â tn
Utdelning
0,33Â %
Kvartalsvis utdelning
1,50Â INR
Ex-utdelningsdatum
7 aug. 2026
P/E-tal
35,74
52v högst
2Â 039,30Â INR
52v lägst
1Â 252,95Â INR
EPS
51,63Â INR
Utestående aktier
126,35Â mn
Antal anställda
17Â tn
Öppen
1Â 913,95Â INR
Högt
1Â 913,95Â INR
LÃ¥gt
1Â 812,60Â INR
Börsvärde
468,21Â md
Genomsn. vol.
27,90Â tn
Volym
12,00Â tn
Utdelning
0,33Â %
Kvartalsvis utdelning
1,50Â INR
Ex-utdelningsdatum
7 aug. 2026
P/E-tal
35,74
52v högst
2Â 039,30Â INR
52v lägst
1Â 252,95Â INR
EPS
51,63Â INR
Utestående aktier
126,35Â mn
Antal anställda
17Â tn
Nyheter och artiklar
Från webbkällor och nyhetspartner
HurBra.se
·
för 2 dagar sedan
USA-börsen 15 oktober 2026: Vård lyfte, AI pressades
Simply Wall Street
·
för 14 minuter sedan
Did FDA Filings Just Shift Cogent Biosciences Stock Investment Narrative?
Yahoo Finance
·
för 4 timmar sedan
Michael Burry Warns Stock Market Could Be Months Away From A 2000-Style Reckoning — ‘The Preconditions Seem Set For Fireworks’
The Motley Fool
·
för 59 minuter sedan
Should You Invest in the S&P 500 Right Now or Wait? There's 1 Clear Answer
Profil
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
Om IPCA Laboratories Ltd